Cargando…
A Heterologous Viral Protein Scaffold for Chimeric Antigen Design: An Example PCV2 Virus Vaccine Candidate
Recombinant vaccines have low-cost manufacturing, regulatory requirements, and reduced side effects compared to attenuated or inactivated vaccines. In the porcine industry, post-weaning multisystemic disease syndrome generates economic losses, characterized by progressive weight loss and weakness in...
Autores principales: | Lamazares, Emilio, Gutiérrez, Fernando, Hidalgo, Angela, Gutiérrez, Nicolas A., Espinoza, Felipe I., Sánchez, Oliberto, Cortez-San Martín, Marcelo, Mascayano, Carolina, González, Javier, Saavedra, José, Altamirano, Claudia, Mansur, Manuel, Ruiz, Álvaro, Toledo, Jorge R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232224/ https://www.ncbi.nlm.nih.gov/pubmed/32244384 http://dx.doi.org/10.3390/v12040385 |
Ejemplares similares
-
Comparative Efficacy of Chimeric Porcine Circovirus (PCV) Vaccines against Experimental Heterologous PCV2d Challenges
por: Wongchanapai, Pichanun, et al.
Publicado: (2023) -
Evaluation of the Efficacy and Cross-Protective Immunity of Live-Attenuated Chimeric PCV1-2b Vaccine Against PCV2b and PCV2d Subtype Challenge in Pigs
por: Huan, Changchao, et al.
Publicado: (2018) -
Comparative efficacy of experimental inactivated and live-attenuated chimeric porcine circovirus (PCV) 1-2b vaccines derived from PCV1 and PCV2b isolates originated in China
por: Li, Jizong, et al.
Publicado: (2015) -
Reduction of porcine circovirus type 2 (PCV2) viremia by a reformulated inactivated chimeric PCV1-2 vaccine-induced humoral and cellular immunity after experimental PCV2 challenge
por: Seo, Hwi Won, et al.
Publicado: (2012) -
In vivo characterization of chimeric PCV DNA clones containing heterogeneous capsid protein nuclear localization signals (NLS)
por: Shuai, Jiangbing, et al.
Publicado: (2013)